Peho-like syndrome is a rare genetic condition that affects development of the brain and nervous system. It usually begins in infancy and features severe developmental delay, seizures, low muscle tone, and vision problems. Many people with Peho-like syndrome also have small head size, distinctive facial features, and swelling of hands and feet in early life. Care focuses on seizure control, feeding and nutrition, physical and vision therapies, and supportive care, and advances in care mean people often manage well with treatment. The outlook varies by severity, and some children have serious medical complications that can affect life expectancy.
Overview
Peho-like syndromeSymptoms
Peho-like syndrome features begin in early infancy: poor muscle tone, feeding difficulties, and developmental delay. Many have hard-to-control seizures and periods of unusual body stiffness or jerking. Doctors may also note swelling, small head size, vision concerns, and slow growth.
Outlook and prognosis
Peho-like syndrome is lifelong, but supportive therapies can ease daily challenges and help many reach personal milestones. Development typically remains delayed, and seizures or vision and movement issues may persist or fluctuate. Regular follow-up with neurology, rehabilitation, and vision care guides plans over time.
Causes and risk factors
Peho-like syndrome usually stems from inherited, autosomal recessive gene variants; parents are typically healthy carriers. Risk is higher with a family history or parental relatedness; no proven environmental or lifestyle causes are known.
Genetic influences
Genetics is central in Peho-like syndrome. Most cases stem from inherited or de novo gene variants that disrupt brain and nerve development. Genetic testing can confirm the diagnosis, guide care, clarify recurrence risk, and support family planning.
Diagnosis
Doctors suspect it from early developmental signs, seizures, eye findings, and characteristic brain changes on MRI and EEG. Genetic tests, often via panels or exome sequencing, confirm the genetic diagnosis of Peho-like syndrome and exclude similar disorders.
Treatment and drugs
Treatment focuses on supportive care: seizure control, tailored feeding support, and therapies to aid mobility, vision, and communication. Care teams often include neurology, nutrition, physiotherapy, and ophthalmology. Regular reviews help adjust medicines and equipment as Peho-like syndrome needs evolve.
Symptoms
Families often notice challenges with movement, feeding, and alertness in early infancy. Early features of Peho-like syndrome may include low muscle tone, seizures, vision problems, and feeding difficulties that affect day-to-day care. Features vary from person to person and can change over time.
Babies may feel floppy and have trouble holding up their head. This can make feeding and moving harder. Therapies can support posture and strength.
Brief, repeated jerks or stiffening can occur, often in clusters. Clinicians call this infantile spasms, which means sudden bursts of muscle tightening in early infancy. Seizures can affect alertness and sleep.
Skills like rolling, sitting, and babbling may emerge later than expected. Loved ones often notice the changes first. Ongoing therapies can help with communication and mobility.
Limited eye contact and poor tracking of faces or toys can be present. In Peho-like syndrome, this often ties to optic nerve damage, leading to reduced vision.
How people usually first notice Peho-like syndrome?
Parents and clinicians often first notice Peho-like syndrome in early infancy when a baby has very low muscle tone, feeding difficulties, and seizures that start in the first months of life. Over time, there may be slowing or loss of developmental milestones and changes a doctor sees on eye exam, which prompts genetic testing to confirm the diagnosis—these are the first signs of Peho-like syndrome that lead families to seek answers. In some cases, prenatal ultrasound or early postnatal exams may show small head size and brain changes, but most families recognize something is wrong when seizures and developmental concerns appear.
Types of Peho-like syndrome
Peho-like syndrome is a rare genetic condition. It has more than one recognized clinical variant, and these variants can differ in age at onset, movement challenges, and how quickly problems progress. People may notice different sets of symptoms depending on their situation. When reading about types of Peho-like syndrome, you’ll often see differences tied to the specific gene involved and whether changes are the same on both copies of the gene.
CEMIP2-related type
This variant is linked to changes in the CEMIP2 gene and often presents in infancy with low muscle tone and developmental delay. Seizures may occur early and vision can be affected over time.
ZNHIT3-related type
This form involves ZNHIT3 gene changes, with early-life low tone, feeding challenges, and slower skill gains. Some children develop seizures and movement stiffness as they grow.
KIF1A-related type
Variants in KIF1A can produce a Peho-like picture with coordination difficulties and progressive movement symptoms. Vision problems and learning challenges may become more noticeable in school years.
TBCD-related type
Changes in the TBCD gene can lead to early developmental delay and seizures. Breathing control and muscle tone can fluctuate, and some features may progress with time.
WDR45-related type
In this variant, early development may be slow, with later-onset movement tightening and episodes of seizures. Vision and attention can be affected as daily demands increase; types of Peho-like syndrome can vary in severity.
What genetics can tell you about symptoms
Some people with Peho-like syndrome have variants in the CCDC88A (Girdin) gene, which can disrupt brain wiring and lead to early-onset seizures, low muscle tone, and developmental delays. Changes in this gene may also affect eye development, causing optic nerve atrophy and vision loss.
Causes and risk factors
Peho-like syndrome is mainly caused by changes in genes that guide early brain and nerve development. Many cases are inherited in an autosomal recessive pattern, so risk is higher when both parents are carriers. Some risks are written in our DNA, passed down through families. Some cases also happen as new changes with no family history, and no environmental or lifestyle trigger has been proven to cause it. If there is a family history or early symptoms of Peho-like syndrome in a child, consider a genetics visit to discuss carrier testing and future pregnancy risks.
Environmental and biological risk factors
Peho-like syndrome is a very rare neurodevelopmental condition that begins before birth. Many families first notice early symptoms of Peho-like syndrome in the first months of life, but the factors that increase likelihood are largely set much earlier. Awareness of both biological and environmental influences helps you feel prepared. Below are the environmental and biological elements that are known—or notably not known—to affect risk.
No specific exposures have been linked to this rare condition. Studies have not shown consistent ties with pollutants, radiation, or heavy metals. Evidence remains limited given how rare it is.
The factors behind this condition arise very early in fetal brain and nerve development. These biology-based risks are present before birth. They are not known to be shifted by short-term changes during pregnancy.
Unlike some conditions, advanced maternal or paternal age has not been proven to raise risk for Peho-like syndrome. Available case reports do not show a clear age pattern. No age threshold has been identified.
Common pregnancy infections like rubella, cytomegalovirus, or toxoplasmosis have not been shown to cause this syndrome. When present, such infections can affect fetal development in other ways. Staying up to date with recommended prenatal care helps protect overall pregnancy health.
Genetic risk factors
Peho-like syndrome is most often tied to rare changes in single genes that guide early brain and nerve development. Many families show an autosomal recessive pattern, with parents as healthy carriers of one altered copy. Because early symptoms of Peho-like syndrome overlap with other conditions, genetic testing can confirm the cause and help with family planning. In some cases, genetic testing can give a clearer picture of your personal risk.
Autosomal recessive pattern: Most reported families with Peho-like syndrome have two nonworking copies of the same gene. Parents are usually healthy carriers, and each pregnancy has a 25% chance of an affected child. Carrier children typically have no symptoms.
Genetic heterogeneity: Different genes can lead to the same Peho-like syndrome features. This is why broad testing, such as a multi-gene panel or exome sequencing, is often used to find the exact cause. Pinpointing the gene helps refine recurrence risks for relatives.
De novo variants: In a minority of children, the genetic change is new in the child and not present in either parent. Recurrence risk is usually low in these families. Testing both parents helps confirm whether a variant is de novo.
X-linked causes: Rare changes on the X chromosome can produce a Peho-like picture. In these families, risks for future children may differ for boys and girls depending on who carries the change.
Parental relatedness: When parents are related by blood, they have a higher chance of carrying the same rare change. This increases the likelihood of an autosomal recessive condition in a child.
Family history clues: Having more than one affected sibling points toward a recessive cause. Extended family members may be healthy carriers. This can guide testing and planning.
Ancestry clusters: In some communities or regions, a rare change can be more common due to a founder effect. Families from these backgrounds may have a higher chance of sharing the same variant. Targeted tests may be available if a local founder change is known.
Variable expression: People with the same gene change can have different severity and timing of features. This variability makes outcomes in Peho-like syndrome hard to predict early on. People with the same risk factor can have very different experiences.
Lifestyle risk factors
Peho-like syndrome is a genetic, congenital condition; lifestyle habits do not cause it, but daily routines can influence symptom control and complications over time. Thoughtful choices around feeding, movement, sleep, and caregiving can reduce risks such as aspiration, constipation, contractures, and pressure injuries. This overview explains how lifestyle affects Peho-like syndrome by highlighting practical factors families can modify.
Insufficient calories or protein can worsen poor growth and energy for therapy participation. Tailored, calorie-dense meals and texture modifications support safer swallowing and weight maintenance.
Fast pacing, large bites, or flat positioning increase choking and aspiration risk in hypotonia. Slow, upright, and therapist-guided techniques make feeds safer and reduce respiratory complications.
Prolonged inactivity promotes joint contractures, weak bones, and constipation in children with hypotonia. Regular assisted range-of-motion and supported sitting or standing help preserve mobility and bowel regularity.
Sleep deprivation can lower the seizure threshold and worsen daytime irritability. Consistent bedtimes and calming routines may strengthen seizure control and daytime function.
Risk prevention
Peho-like syndrome is a rare genetic condition, so preventing the condition itself isn’t currently possible. Prevention focuses on lowering the chance of complications and catching issues early so care can start promptly; early symptoms of Peho-like syndrome may be subtle in infancy. Some prevention is universal, others are tailored to people with specific risks. Families planning future pregnancies can also consider genetic counseling to understand options.
A genetics team can review your family’s history and discuss testing to clarify risks of Peho-like syndrome in future pregnancies. They can explain options such as carrier testing, prenatal testing, or IVF with embryo testing if a causative variant is known.
If the genetic change causing Peho-like syndrome is identified, prenatal or preimplantation testing may help avoid passing it on. Decisions are personal and guided by values, medical details, and local regulations.
Regular check-ins in the first year can spot low muscle tone, feeding trouble, or early seizures sooner. Early detection allows supportive therapies and seizure care to begin before problems snowball.
Work with neurology to choose medicines and a clear rescue plan to prevent prolonged seizures. Consistent sleep, avoiding missed doses, and managing fevers can also lower seizure triggers in Peho-like syndrome.
Transmission
Peho-like syndrome isn’t contagious and can’t be caught or spread between people. It’s a genetic condition, and in many families it follows an autosomal recessive pattern—both parents carry a silent gene change and have a 1 in 4 (25%) chance in each pregnancy of having a child with the condition. In other cases, Peho-like syndrome happens because of a new, spontaneous change in a single gene that isn’t inherited from either parent; if this is the cause, the chance of it happening again is usually low but can vary. A genetics professional can explain how Peho-like syndrome is inherited for your family and discuss testing options.
When to test your genes
Consider genetic testing if a child shows early-onset developmental delay, seizures, reduced muscle tone, or vision/hearing concerns, especially with brain imaging changes or “dysmorphic” facial features noted by clinicians. Testing is also reasonable when a sibling is affected or parents are consanguineous. Results can confirm diagnosis, guide care, and clarify recurrence risks.
Diagnosis
Peho-like syndrome is usually recognized early in life when delays in development and changes in muscle tone appear alongside distinctive physical features. Doctors look at the overall pattern rather than any single sign, then use targeted tests to confirm the cause. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of Peho-like syndrome typically combines careful clinical evaluation with genetic tests.
Providers look for a pattern of early developmental delay, low or changing muscle tone, and distinctive facial and body features. Seeing several features together raises suspicion more than any single sign.
A detailed timeline of motor, speech, and social milestones helps map how delays started and changed. Notes from therapists or early intervention services can add helpful detail.
Doctors assess reflexes, muscle tone, movement, and feeding or swallowing. This bedside exam guides which tests to order next.
An EEG checks brain wave patterns if seizures or unusual spells are a concern. Findings can support a neurologic cause and help rule out other seizure types.
Stages of Peho-like syndrome
Peho-like syndrome does not have defined progression stages. Different tests may be suggested to help confirm what’s going on and rule out similar conditions. In practice, doctors look at early symptoms of Peho-like syndrome, a detailed neurological exam, and results from tools like brain MRI, eye examinations, and EEG; genetic testing may also be offered to look for an underlying cause. Ongoing care usually tracks growth, muscle tone, vision, and seizure control over time to guide treatment and support.
Outlook and prognosis
Looking at the long-term picture can be helpful. Peho-like syndrome tends to involve significant developmental delays from infancy, ongoing seizures for many, and progressive challenges with movement, vision, and hearing. Daily routines often adapt, like scheduling therapies around seizure patterns or using specialized seating and feeding supports as muscle tone changes. Many people ask, “What does this mean for my future?”, and the honest answer is that abilities often plateau or slowly decline, with most children requiring lifelong, full-time care.
The outlook is not the same for everyone, but the condition is generally serious. Some children have seizures that respond to medicine, while others continue to have frequent episodes that affect sleep, learning, and energy. Breathing difficulties, recurrent infections, feeding problems, and issues with temperature control can occur and may lead to hospital stays. In severe cases, especially when seizures are hard to control and medical complications stack up, Peho-like syndrome can shorten lifespan, sometimes into childhood; others live into adolescence or adulthood with comprehensive support.
Understanding the prognosis can guide planning and help families focus on comfort, seizure safety, nutrition, mobility, and vision and hearing support. Early care can make a real difference by preventing complications and addressing early symptoms of Peho-like syndrome, even though it does not change the underlying genetic cause. With ongoing care, many people maintain the best quality of life possible for their situation, and care teams can revisit goals as needs evolve. Talk with your doctor about what your personal outlook might look like, including how seizure control, feeding strategies, and respiratory care may shape the years ahead.
Long-term effects
Peho-like syndrome is a rare, genetic neurodevelopmental condition with effects that tend to unfold from infancy into later childhood. Early symptoms of Peho-like syndrome often appear in the first months of life and set the stage for long-term patterns. Long-term effects vary widely, and the course may change over time. Many families see periods of stability mixed with gradual changes in movement, vision, or health complications.
Most children have profound delays in learning, speech, and daily skills. Many do not develop spoken language and rely on nonverbal ways to communicate. Skills may plateau or gradually lessen over time.
Seizures often begin in infancy and can be hard to control. Patterns may shift with age, and periods of frequent seizures can alternate with quieter stretches. Some children with Peho-like syndrome have persistent daily seizures.
Optic nerve damage can lead to severe vision loss or blindness. Eye contact and tracking may be limited from early childhood. Vision can decline as the condition progresses.
Progressive microcephaly (a small head size) often emerges after birth. Head growth may slow over time even when overall body growth continues. This reflects ongoing brain changes seen in Peho-like syndrome.
How is it to live with Peho-like syndrome?
Living with Peho-like syndrome often means round-the-clock care, because children typically have profound developmental delays, seizures that can be difficult to control, and low muscle tone that affects feeding, movement, and breathing. Daily life revolves around therapies, seizure management, assistive equipment, and frequent medical visits, with small gains celebrated and setbacks expected. Families and caregivers may feel stretched by sleep disruption, complex medication schedules, and coordination of services, yet many also find strong support networks and routines that bring steadier days. Siblings, relatives, and school teams are part of the care circle, adapting expectations and communication to help the child participate safely and comfortably.
Treatment and drugs
Treatment for Peho-like syndrome focuses on easing symptoms, supporting development, and preventing complications, since there’s no single cure. Care teams often include neurology, rehabilitation, nutrition, and eye specialists to address seizures, movement and muscle tone challenges, feeding issues, and vision problems; doctors sometimes recommend a combination of lifestyle changes and drugs. Seizures are usually treated with anti-seizure medicines, with the dose adjusted carefully to balance control and side effects, and some children may benefit from add-on options if seizures are hard to manage. Physical, occupational, and speech therapies aim to maintain comfort, maximize mobility and communication, and help with daily activities, while nutrition support—such as high-calorie feeds or a feeding tube if needed—can improve energy and growth. Regular follow-up helps refine the plan as needs change over time, and supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Families often juggle feeding, movement, and communication challenges each day. In Peho-like syndrome, a team-based plan focuses on comfort, development, and safety at home and in clinic. Alongside medicines, non-drug therapies can improve daily function and ease strain on caregivers. Early symptoms of Peho-like syndrome, like poor feeding or low muscle tone, can guide which therapies start first.
Gentle stretching, positioning, and guided movement help maintain joint range and reduce stiffness. Therapists teach safe handling and ways to support head and trunk control. Home programs make practice easier between visits.
Daily activities like dressing, bathing, and play are broken into manageable steps. Therapists suggest adaptive tools to improve grasp and comfort. They also work on sensory calming strategies.
Therapy targets safe swallowing and more efficient feeding. Strategies may include pacing, thicker fluids, or specific nipple shapes. Early swallowing assessment can lower the risk of aspiration.
Low-vision services use high-contrast objects, lighting tweaks, and tactile cues to build engagement. Orientation and mobility training supports safe movement in familiar spaces. Families learn to read subtle visual responses.
Your genes may have an impact on how drugs work for you
Even when two children share a diagnosis, their bodies can handle the same medicine very differently because genes shape how drugs are absorbed, broken down, and cleared. In Peho-like syndrome, genetics may affect dosing, side‑effect risk, and which seizure or symptom medicines work best.
Pharmacological treatments
Peho-like syndrome does not have a cure, so medicines focus on easing day-to-day symptoms like seizures, stiffness, sleep issues, and feeding-related problems. Not everyone responds to the same medication in the same way. Drug choices are tailored with a child’s neurologist and pediatric team, balancing benefits with side effects. Plans often change over time as symptoms evolve.
ACTH injections or oral prednisolone are commonly used first for spasms. Vigabatrin may be added or used when spasms are linked to certain patterns on EEG, which can be among the early symptoms of Peho-like syndrome.
Levetiracetam, valproate, topiramate, or clobazam are often used to reduce seizure frequency. Doctors may combine drugs if seizures remain frequent in Peho-like syndrome.
Rectal diazepam or intranasal midazolam can stop a prolonged seizure at home. Your team will give clear instructions on when and how to use them.
Clonazepam or levetiracetam may ease myoclonus or jittery movements. Doses are adjusted slowly to balance benefit and sleepiness.
Genetic influences
For many families, Peho-like syndrome has a genetic basis and is often inherited in an autosomal recessive way. In this pattern, both parents quietly carry one nonworking copy of a gene and stay healthy; if a child receives two changed copies, the condition can develop. A “carrier” means you hold the gene change but may not show symptoms. Different genes that guide early brain development and nerve cell function have been linked to Peho-like syndrome, so there isn’t a single “main” gene in every case. Because of this, broad genetic testing—such as a multigene panel or exome/genome sequencing—can help find the cause, confirm the diagnosis, and clarify chances for future children (about a 25% risk with each pregnancy when both parents are carriers). Genetic results may also explain early symptoms of Peho-like syndrome and guide care planning for your child and family.
Is Peho-like syndrome genetic?
Genetics is central in Peho-like syndrome. Most cases stem from inherited or de novo gene variants that disrupt brain and nerve development. Genetic testing can confirm the diagnosis, guide care, clarify recurrence risk, and support family planning.
Pharmacogenetics—how genetics influence drug effects
For Peho-like syndrome, the genetic diagnosis mainly guides overall care and expectations, but it rarely points to a single “right” medicine. Two children on the same seizure drug can have very different experiences—one gets too sleepy on a small dose, while another needs more to see benefit. Genetic testing can sometimes identify how your body handles certain seizure medicines, which can help doctors choose a safer starting dose and follow-up plan. Pharmacogenetic testing in Peho-like syndrome isn’t a routine, condition-specific roadmap; choices rely on symptoms, past responses, and well-studied drug–gene pairs used in epilepsy care. Differences in genes that control liver enzymes can make medicines like phenytoin or clobazam build up (causing side effects) or clear too fast (reducing benefit), so doses sometimes need adjusting. For carbamazepine and related drugs, a known genetic marker can greatly raise the risk of a serious skin reaction, so testing may be recommended before starting, especially for people with at‑risk ancestry. If features suggest a mitochondrial disorder, clinicians often avoid valproate because of liver risks in that setting, and they may choose alternatives with careful monitoring.
Interactions with other conditions
Living day-to-day with Peho-like syndrome often also involves epilepsy, feeding difficulties, reflux, and frequent chest or airway infections, and these can influence one another. Doctors call it a “comorbidity” when two conditions occur together. Seizures and the medicines used to control them may cause sleepiness or reduce muscle coordination, which can make swallowing less safe and raise the chance of aspiration and pneumonias. Low muscle tone and reflux can make feeding harder, and poor weight gain can lower reserves to fight infections or recover after illness. Vision loss or hearing problems that can accompany Peho-like syndrome may compound developmental delays, and early symptoms of Peho-like syndrome such as infantile spasms often mean shared care with epilepsy specialists from the start. If scoliosis or joint stiffness develops, chest expansion can be limited, so respiratory infections may feel more severe and take longer to clear.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described infants who were unusually quiet, had low muscle tone, and later developed seizures and vision problems, yet the underlying cause was unclear. Families and clinicians noticed that development stalled early and that care needs were high from the first months of life. Medical records from the late 20th century began linking these early-life patterns with distinctive brain and eye findings on exam and imaging, but the label varied from clinic to clinic.
First described in the medical literature as a condition resembling a severe infant-onset neurodevelopmental disorder seen in Northern Europe, it later became known as Peho-like syndrome when children had many of the same features but did not fit every detail of the original reports. Over time, descriptions became more precise as specialists compared notes: low muscle tone in infancy, seizures that were hard to control, profound developmental delays, and optic nerve changes that affected vision. Some children were noted to have changes in growth of the brain on scans, which helped doctors see this as a consistent pattern rather than unrelated symptoms.
Advances in genetics helped move the field beyond names based only on symptoms. In recent decades, knowledge has built on a long tradition of observation, and gene testing has connected Peho-like syndrome in some families to rare changes in specific genes that affect how brain cells develop and communicate. This shift—from describing what doctors saw to identifying changes at the DNA level—clarified why the condition can look similar across different children and why there is still variation from child to child.
Not every early description was complete, yet together they built the foundation of today’s knowledge. What was once grouped under broader labels is now recognized as Peho-like syndrome when the clinical picture aligns, sometimes supported by genetic results. This history explains why you may see slightly different names in older records and why a detailed clinical evaluation remains essential. Looking back helps explain how today’s care focuses on early seizure control, vision support, and developmental therapies, while ongoing research continues to refine the genetics and deepen understanding of this rare condition.